Related references
Note: Only part of the references are listed.Medical Therapy of Malignant Bowel Obstruction With Octreotide, Dexamethasone, and Metoclopramide
Jeffrey Berger et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2016)
Olanzapine in the Management of Difficult to Control Nausea and Vomiting in a Palliative Care Population: A Case Series
David MacKintosh
JOURNAL OF PALLIATIVE MEDICINE (2016)
Use of olanzapine for the relief of nausea and vomiting in patients with advanced cancer: a multicenter survey in Japan
Keisuke Kaneishi et al.
SUPPORTIVE CARE IN CANCER (2016)
Double-Blind, Placebo-Controlled, Randomized Trial of Octreotide in Malignant Bowel Obstruction
David C. Currow et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2015)
Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer
Xingang Peng et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Dronabinol Treatment of Refractory Nausea and Vomiting Related to Peritoneal Carcinomatosis
Sarah L. Hernandez et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2015)
Levomepromazine for nausea and vomiting in palliative care
Lalage Cox et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
A Randomized Trial of the Effectiveness of Topical ABH Gel'' (Ativan®, Benadryl®, Haldol®) vs. Placebo in Cancer Patients With Nausea
Devon S. Fletcher et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2014)
Olanzapine for Intractable Nausea and Vomiting in Palliative Care Patients Not Receiving Chemotherapy
Sean R. Atkinson
JOURNAL OF PALLIATIVE MEDICINE (2014)
Sublingually administered scopolamine for nausea in terminally ill cancer patients
Kengo Imai et al.
SUPPORTIVE CARE IN CANCER (2013)
Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review
Isabel Dietz et al.
BMC PALLIATIVE CARE (2013)
Levomepromazine for nausea and vomiting in palliative care
Emily Darvill et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
A Prospective Study on the Efficacy of Octreotide in the Management of Malignant Bowel Obstruction in Gynecologic Cancer
Hidemichi Watari et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
Pascale Mariani et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Olanzapine for the Relief of Nausea in Patients With Advanced Cancer and Incomplete Bowel Obstruction
Keisuke Kaneishi et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2012)
Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations
Eivor A. Laugsand et al.
PALLIATIVE MEDICINE (2011)
Treating nausea and vomiting in palliative care: a review
Paul Glare et al.
CLINICAL INTERVENTIONS IN AGING (2011)
Multicenter Prospective Study on Efficacy and Safety of Octreotide for Inoperable Malignant Bowel Obstruction
Takayuki Hisanaga et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
The Efficacy of Haloperidol in the Management of Nausea and Vomiting in Patients with Cancer
Janet R. Hardy et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Scopolamine for Cancer-Related Nausea and Vomiting
Susan B. LeGrand et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
A Systematic Review of the Treatment of Nausea and/or Vomiting in Cancer Unrelated to Chemotherapy or Radiation
Mellar P. Davis et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Malignant Irreversible Intestinal Obstruction: The Powerful Association of Octreotide to Corticosteroids Antiemetics, and Analgesics
Catherine Weber et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2009)
Efficacy of Granisetron in the Antiemetic Control of Nonsurgical Intestinal Obstruction in Advanced Cancer: A Phase II Clinical Trial
Albert Tuca et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
Haloperidol for the treatment of nausea and vomiting in palliative care patients
Paul Perkins et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer
J Stephenson et al.
SUPPORTIVE CARE IN CANCER (2006)
Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: A randomized controlled trial
E Bruera et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dosed of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients
J Hardy et al.
SUPPORTIVE CARE IN CANCER (2002)
Use of clinical pictures in the management of nausea and vomiting: a prospective audit
A Bentley et al.
PALLIATIVE MEDICINE (2001)
A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer
E Bruera et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)
Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction
S Mercadante et al.
SUPPORTIVE CARE IN CANCER (2000)
Share Paper
